IFP Advisors’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-421
Closed -$4.17K – 5271
2026
Q2
$4.17K Buy
421
+378
+879% +$3.16K ﹤0.01% 3890
2026
Q1
$264 Buy
+43
New +$358 ﹤0.01% 4565
2025
Q4
– Sell
-27
Closed -$394 – 4920
2025
Q3
$394 Buy
27
+1
+4% +$12 ﹤0.01% 4245
2025
Q2
$293 Buy
26
+12
+86% +$93 ﹤0.01% 4559
2025
Q1
$80 Hold
14
– – ﹤0.01% 3921
2024
Q4
$137 Sell
14
-575
-98% -$4.93K ﹤0.01% 3913
2024
Q3
$249 Buy
589
+572
+3,365% +$5.73K ﹤0.01% 3199
2024
Q2
$226 Sell
17
-8
-32% -$239 ﹤0.01% 3140
2024
Q1
$1.14K Hold
25
– – ﹤0.01% 2836
2023
Q4
$1.67K Buy
25
+3
+14% +$184 ﹤0.01% 2715
2023
Q3
$1.62K Hold
22
– – ﹤0.01% 2888
2023
Q2
$1.63K Buy
22
+8
+57% +$474 ﹤0.01% 2942
2023
Q1
$7K Sell
14
-2,006
-99% -$127K ﹤0.01% 2430
2022
Q4
$985K Sell
2,020
-12
-0.6% -$1.1K 0.03% 626
2022
Q3
$991K Buy
2,032
+370
+22% +$44.1K 0.03% 641
2022
Q2
$810K Hold
1,662
– – 0.03% 648
2022
Q1
$810K Buy
1,662
+1,639
+7,126% +$319K 0.03% 648
2021
Q4
$7K Hold
23
– – ﹤0.01% 2340
2021
Q3
$10K Buy
+23
New +$11.2K ﹤0.01% 2264

Other funds holding DNA

IFP Advisors's DNA Position: Q3 2026 in Review

IFP Advisors sold out of Ginkgo Bioworks (DNA) in Q3 2026, closing a stake of 421 shares — an estimated $4.17K sold.

IFP Advisors first reported a position in DNA in Q3 2021 and held it in 19 quarters. The position peaked at $991K in Q3 2022. 33 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • IFP Advisors reported no remaining Ginkgo Bioworks position as of Q3 2026 after selling out during the quarter.
  • IFP Advisors sold 421 Ginkgo Bioworks shares in Q3 2026, an estimated $4.17K.
  • IFP Advisors first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 19 quarters.
  • IFP Advisors's Ginkgo Bioworks position peaked at $991K in Q3 2022.
  • 33 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.